Abstract
- •
COVID-2019 pandemic represents a great challenge both in itself and for time-sensitive diseases.
- •
Head and neck cancer surgery is a high risk procedure for COVID-19.
- •
Possibility of SARS-CoV-2 false negative at pre-operative evaluation in asymptomatic subjects should not let guard down in the post-operative time.
Keywords:
COVID-19; Coronavirus; Head and neck cancer; Head and neck surgery.
MeSH terms
-
Aged
-
Betacoronavirus / genetics
-
Betacoronavirus / isolation & purification*
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Testing
-
Clinical Laboratory Techniques / standards*
-
Clinical Laboratory Techniques / statistics & numerical data
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / prevention & control*
-
Coronavirus Infections / transmission
-
False Negative Reactions
-
Female
-
Head and Neck Neoplasms / surgery*
-
Humans
-
Infection Control / instrumentation
-
Infection Control / standards
-
Infectious Disease Transmission, Patient-to-Professional / prevention & control
-
Infectious Disease Transmission, Professional-to-Patient / prevention & control
-
Italy / epidemiology
-
Male
-
Nasopharynx / surgery
-
Nasopharynx / virology
-
Otorhinolaryngologic Surgical Procedures / standards*
-
Otorhinolaryngologic Surgical Procedures / statistics & numerical data
-
Pandemics / prevention & control*
-
Personal Protective Equipment / standards
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / prevention & control*
-
Pneumonia, Viral / transmission
-
Preoperative Care / instrumentation
-
Preoperative Care / standards
-
Preoperative Care / statistics & numerical data
-
RNA, Viral / isolation & purification
-
SARS-CoV-2
-
Surgical Oncology / standards*
-
Tertiary Care Centers / statistics & numerical data
-
Time-to-Treatment